Cortical Visual Impairment: An Approach to Assessment and Intervention, 2nd Edition(Print)
by American Printing House for the Blind
Price is what the vendor listed when last checked. Confirm it with the vendor before buying.
What it is
Summary
AI-generated from vendor-published content · October 1, 2026
This is a print book that explains cortical visual impairment (CVI) and lays out a full approach for assessing a child and planning support. It is written for the whole team around a child with CVI, including teachers, therapists, physicians, and parents. This is the second edition, and it is a reference to read and work from, not a tool the child uses directly.
Getting it
Many states lend devices like this for trial periods, free or at low cost — find your state's AT lending program.
Where to get it
This is the vendor WhatCanHelp tracks for this product — it may also be available from other retailers or a local supplier, and prices vary.
How to fund this
These are common places to ask about paying for equipment like this. Each one decides its own eligibility and what it covers, so start by asking them.
Details
Quick Facts Catalog facts · auto-generated
- Addresses
- Platform
- Age range
- Complexity
- Professional guidance helps
- Price
- $76.95
- Funding
- Out of pocket
- School district
What setup looks like
- Out of the box
- Read the book as a reference; nothing needs to be set up or plugged in.
- It is made to order, so plan on roughly 10-14 business days before it ships.
- With a guide
- Share the book with the child's team so parents, teachers, and therapists work from the same framework.
- Turning the framework into a plan for one child goes best with a teacher of students with visual impairments or a vision specialist.
Compare & explore
Sources & fine print
Vendor facts (name, price, platforms, vendor link) sourced from American Printing House for the Blind — view on vendor site (opens in a new tab); last checked November 1, 2026.
Classification & description AI-generated from vendor-published content on October 1, 2026 · confidence: high. Vendor specs may lag; verify before relying on details in a clinical or funding artifact.